DIVISLAB's weekly return of -1.39% was disappointing, with a Sharpe Ratio of -0.50 indicating poor risk-adjusted performance. The stock's volatility of 11.14% was relatively high, and its Max Drawdown of -1.39% suggests significant price fluctuations. Compared to peers, DIVISLAB underperformed SUNPHARMA and DRREDDY, but outperformed CIPLA. Overall, the stock was relatively risky this week.

[Volatility: 11.14%]